Edward Arous, MD
Vascular Surgery · Worcester, MANPI 1982999199
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Philips North America LLC at 51.0% of the total. Reporting peaked in 2023 at $16,385 and has fallen 91.1% since, to $1,455 in 2025.
Across 246 payments — averaging $118.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$15K
- Medtronic$4K
- Veryan Medical Incorporated$2K
- Penumbra, Inc.$2K
- Silk Road Medical, Inc.$1K
- Boston Scientific$911
- plus $4K from 23 others
Across 29 payments — averaging $12,655 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- M.a. Med Alliance S.A.$360K
- Medalliance LLC$8K
What the payments were for
- Consulting fees$2,1817%
- Speaking & faculty fees$11,30039%
- Travel & lodging$3,41412%
- Food & beverage$10,25235%
- Education$1,9507%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 25 | $14,851 |
| Medtronic | 98 | $4,079 |
| Veryan Medical Incorporated | 4 | $2,496 |
| Penumbra, Inc. | 8 | $1,781 |
| Silk Road Medical, Inc. | 12 | $1,439 |
| Boston Scientific | 35 | $911 |
| Aesculap Implant Systems, LLC | 4 | $637 |
| Endologix LLC | 8 | $569 |
| Johnson & Johnson | 16 | $510 |
| Cook Medical LLC | 3 | $471 |
| W. L. Gore & Associates, Inc. | 2 | $247 |
| Bard Peripheral Vascular, Inc. | 2 | $174 |
| Abbott | 2 | $146 |
| Argon Medical Devices, Inc. | 1 | $99 |
| Bolton Medical Inc | 1 | $98 |
| Tactile Systems Technology Inc | 4 | $73 |
| Organogenesis Inc. | 3 | $70 |
| Cordis US CORP. | 1 | $68 |
| Lemaitre Vascular, Inc. | 3 | $56 |
| Stryker | 2 | $56 |
| Smith+Nephew | 4 | $53 |
| Innovation Technologies Inc | 1 | $49 |
| Aroa Biosurgery Incorporated | 1 | $35 |
| Cvrx, Inc. | 1 | $30 |
| Getinge USA Sales, LLC | 1 | $25 |
| Mimedx Group, Inc. | 1 | $24 |
| Asahi Intecc USA, Inc. | 1 | $19 |
| Sanara Medtech Inc. | 1 | $16 |
| Cardiovascular Systems Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (6554) Periph Vasc Undiv$13,219
- Indigo$2,474
- BioMimics 3D Vascular Stent System$2,181
- ENROUTE Transcarotid Neuroprotection System$1,346
- ENROUTE Transcarotid Stent$1,209
- SilverHawk$800
- QC$647
- ACTIVL ARTIFICIAL DISC$622
- ENDURANT IIS$477
- ELLIPSYS VASCULAR ACCESS SYSTEM$403
- ROSEN$344
- TurboHawk$316
- BioMimics$217
- ENROUTE .014 Guidewire$174
- ENHANCE Transcarotid Peripheral Access Kit$174
- (6554) Peripheral Vascular Undivided$152
- Abre$148
- GORE VIABAHN Endoprosthesis$141
- RotarexS 6 F x 135 cm$141
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$138
How this compares
$29,096 in reported general payments places this provider in the 85th percentile of 142 vascular surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 44 | $38,391 |
| XareltoRivaroxaban | 27 | $26,142 |
| ClopidogrelClopidogrel Bisulfate | 69 | $647 |
| Atorvastatin Calcium | 18 | $280 |
| Oxycodone Hcl | 19 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $510 | $26,14227 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 142 vascular surgery providers in Massachusetts.
Other vascular surgery in Worcester
- Dejah JudelsonWorcester$92K
- Andres SchanzerWorcester$84K
- John NajjarWorcester$10K
- Elizabeth MahanorWorcester$7K
- Elias ArousWorcester$6K
- Thomas OdonnellBoston$845K
- Scott JamesPlymouth$199K
- Anahita DuaBoston$186K
- Jonathan GertlerWeston$90K
- Richard PinNorth Dartmouth$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.